Investor Presentaiton
P&L: Strong Growth in FY22
Revenue € 360.2 M +10.2% | 8.7% organic
(pro forma €386.1 +18.1%)
€ M
FY22
pro forma
FY22
FY21
SW
. Care
Revenue & other income
386.1 360.2 326.9
•
Other
Adjusted Revenue¹
355.6
329.7 298.1
EBITDA
61.8
54.2
49.8
SW
EBITDA % on total revenue
16.0%
15.1%
15.2%
•
Care
•
Other
EBITDA % on adj. revenue
17.4%
16.4%
16.7%
EBIT
31.3
26.0
23.5
EBIT % on total revenue
8.1%
7.2% 7.2%
EBT
21.4
16.8
16.7
Net profit
13.4
9.9
11.3
Note: (1) Net of Temporary Consortia (RTI)
€ 140.5 M +19.5%
€ 168.8 M +1.6%
€ 50.8 M +18.0%
EBITDA € 54.2 M | 16.4% on adj. Revenue
(pro forma €61.8M | 17.4% on adj. Revenue)
€ 37.6 M
€ 6.5 M
€ 10.2 M
26.8% on adj. Revenue
4.7% on adj. Revenue
20.1% on tot. Revenue
EBIT € 26.0 M (pro forma € 31.3 M)
depreciation & amortisation and provisions € 28.2 M
Net Profit € 9.9 M (pro forma € 13.4 M)
tax impact € 6.9 mn (+ € 1.4 M)
net interest expenses € 9.2 (+ €2.4 M)
Proposed dividend € 0.50 p.s.
8View entire presentation